232 related articles for article (PubMed ID: 25448357)
1. Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.
Kiboi D; Irungu B; Orwa J; Kamau L; Ochola-Oyier LI; Ngángá J; Nzila A
Exp Parasitol; 2014 Dec; 147():23-32. PubMed ID: 25448357
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Kiboi DM; Irungu BN; Langat B; Wittlin S; Brun R; Chollet J; Abiodun O; Nganga JK; Nyambati VC; Rukunga GM; Bell A; Nzila A
Exp Parasitol; 2009 Jul; 122(3):196-202. PubMed ID: 19318094
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium berghei: analysis of the gamma-glutamylcysteine synthetase gene in drug-resistant lines.
Pérez-Rosado J; Gervais GW; Ferrer-Rodríguez I; Peters W; Serrano AE
Exp Parasitol; 2002 Aug; 101(4):175-82. PubMed ID: 12594957
[TBL] [Abstract][Full Text] [Related]
4. Amodiaquine resistance in
Ndung'u L; Langat B; Magiri E; Ng'ang'a J; Irungu B; Nzila A; Kiboi D
Wellcome Open Res; 2017; 2():44. PubMed ID: 29946569
[No Abstract] [Full Text] [Related]
5. Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.
Gimode WR; Kiboi DM; Kimani FT; Wamakima HN; Burugu MW; Muregi FW
Malar J; 2015 Jan; 14():38. PubMed ID: 25627576
[TBL] [Abstract][Full Text] [Related]
6. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
7. Is the expression of genes encoding enzymes of glutathione (GSH) metabolism involved in chloroquine resistance in Plasmodium chabaudi parasites?
Ferreira ID; Nogueira F; Borges ST; do Rosário VE; Cravo P
Mol Biochem Parasitol; 2004 Jul; 136(1):43-50. PubMed ID: 15138066
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo.
Dubois VL; Platel DF; Pauly G; Tribouley-Duret J
Exp Parasitol; 1995 Aug; 81(1):117-24. PubMed ID: 7628559
[TBL] [Abstract][Full Text] [Related]
9. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
10. Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite
Ikeda M; Hirai M; Tachibana SI; Mori T; Mita T
Front Cell Infect Microbiol; 2021; 11():672691. PubMed ID: 34222045
[TBL] [Abstract][Full Text] [Related]
11. Infectivity and Screening of Anti-piperaquine Genes in Mice Infected with Piperaquine-Sensitive and Piperaquine-Resistant Plasmodium berghei.
Yi G; Zhou L; Ye Z; Huang X; Lu F; Guo H
Acta Parasitol; 2019 Sep; 64(3):670-678. PubMed ID: 31321598
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei.
Platel DF; Mangou F; Tribouley-Duret J
Mol Biochem Parasitol; 1999 Jan; 98(2):215-23. PubMed ID: 10080390
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model.
Wang H; Bei ZC; Wang JY; Cao WC
Exp Parasitol; 2011 Feb; 127(2):436-9. PubMed ID: 20868687
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P
Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661
[TBL] [Abstract][Full Text] [Related]
15. Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure.
Mwai L; Diriye A; Masseno V; Muriithi S; Feltwell T; Musyoki J; Lemieux J; Feller A; Mair GR; Marsh K; Newbold C; Nzila A; Carret CK
PLoS One; 2012; 7(2):e31623. PubMed ID: 22384044
[TBL] [Abstract][Full Text] [Related]
16. In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum.
Dormoi J; Savini H; Amalvict R; Baret E; Pradines B
Malar J; 2014 May; 13():189. PubMed ID: 24886347
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
18. Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin.
Vega-Rodríguez J; Pastrana-Mena R; Crespo-Lladó KN; Ortiz JG; Ferrer-Rodríguez I; Serrano AE
PLoS One; 2015; 10(5):e0128212. PubMed ID: 26010448
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Glutathione Biosynthesis Sensitizes Plasmodium berghei to Antifolates.
Songsungthong W; Koonyosying P; Uthaipibull C; Kamchonwongpaisan S
Antimicrob Agents Chemother; 2016 May; 60(5):3057-64. PubMed ID: 26953195
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.
Mwangi VI; Mumo RM; Kiboi DM; Omar SA; Ng'ang'a ZW; Ozwara HS
J Infect Dev Ctries; 2016 Jun; 10(6):635-42. PubMed ID: 27367013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
